The company initiated proprietary development of neural interface technology aiming to advance human-machine communication capabilities.
Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development ...
Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation, brain-computer interface (BCI) ...
VisionSys AI Inc. (NASDAQ: VSA) (“VSA” or the “Company”) today announced that it is in advanced discussions with a strategic investor regarding a proposed strategic investment. Based on the terms ...
Researchers have developed printable artificial neurons capable of communicating with living mouse brain cells, marking a milestone in neuromorphic engineering. The technology, detailed in Nature ...
Detailed price information for Wearable Devices Ltd (WLDS-Q) from The Globe and Mail including charting and trades.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips A few weeks ago, a research paper out of MIT (the college) crossed my desk ...
Not only implants are expected to make computer control via the brain possible. A startup is focusing on something much closer to everyday life for many people. For years, companies have been working ...
Neuvotion announced today that it plans to launch its FDA-cleared NeuStim neurostimulation. technology later this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results